FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape EP News Bureau Jul 21, 2025 According to GlobalData, the 2024 approvals included significant milestones in the biosimilar sector, with the FDA granting…
US House panel approves fourth bill on drug prices Reuters Oct 1, 2021 The four measures were part of a package introduced in April to help generic versions of drugs come to market
